Liraglutide, the glucagon‐like peptide‐1 receptor agonist, has anabolic bone effects in diabetic <scp>G</scp>oto‐<scp>K</scp>akizaki rats 利拉鲁肽,一种胰高血糖素样肽‐1受体激动剂,在糖尿病Goto‐Kakizaki大鼠中具有骨合成代谢作用

  • Han‐xiao Sun
    Department of Endocrine and Metabolic Diseases Rui‐jin Hospital Shanghai Jiao‐tong University School of Medicine Shanghai Institute of Endocrine and Metabolic Diseases Shanghai Clinical Center for Endocrine and Metabolic Diseases Shanghai China
  • Nan Lu
    Department of Endocrine and Metabolic Diseases Rui‐jin Hospital Shanghai Jiao‐tong University School of Medicine Shanghai Institute of Endocrine and Metabolic Diseases Shanghai Clinical Center for Endocrine and Metabolic Diseases Shanghai China
  • Xiu Luo
    Department of Endocrine and Metabolic Diseases Rui‐jin Hospital Shanghai Jiao‐tong University School of Medicine Shanghai Institute of Endocrine and Metabolic Diseases Shanghai Clinical Center for Endocrine and Metabolic Diseases Shanghai China
  • Lin Zhao
    Department of Endocrine and Metabolic Diseases Rui‐jin Hospital Shanghai Jiao‐tong University School of Medicine Shanghai Institute of Endocrine and Metabolic Diseases Shanghai Clinical Center for Endocrine and Metabolic Diseases Shanghai China
  • Jian‐min Liu
    Department of Endocrine and Metabolic Diseases Rui‐jin Hospital Shanghai Jiao‐tong University School of Medicine Shanghai Institute of Endocrine and Metabolic Diseases Shanghai Clinical Center for Endocrine and Metabolic Diseases Shanghai China

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ